GOUT CHRONIC

Clinical trials for GOUT CHRONIC explained in plain language.

Never miss a new study

Get alerted when new GOUT CHRONIC trials appear

Sign up with your email to follow new studies for GOUT CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Completed 1

New gout drug shows promise in major trial

Disease control Completed

This study tested a new medicine called AR882 in 818 adults with gout. The goal was to see if it could lower uric acid levels below a target of 6 mg/dL over 6 to 12 months. Participants took either a low dose, a high dose, or a placebo pill. The results will show if AR882 is safe…

Matched conditions: GOUT CHRONIC

Phase: PHASE3 • Sponsor: Arthrosi Therapeutics • Aim: Disease control

Last updated May 15, 2026 11:56 UTC

GOUT CHRONIC

Get alerted when new GOUT CHRONIC trials appear

New gout drug shows promise in major trial